EXPLORE / Sexual health

A more informed conversation about desire.

Understand PT-141, the distinction between desire and erectile function, and why formulation and indication matter.

Explore the formulations.

1 in this topic
PT-141 10mg/ml vial, 5 mL injectable
Sexual health

PT-141

Bremelanotide: understand the indication and formulation.

10mg/ml · 5 mL
$285/ vial · all-inclusive

Product images show the labeled vial for identification; actual pharmacy packaging may differ. Listed strengths are specifications, not dosing instructions.

CONTEXT BEFORE COMMITMENT

Is compounded PT-141 the same as an approved medication?

An FDA-approved bremelanotide product has a specific indication and dosing presentation. A compounded PT-141 formulation is not that approved product and does not inherit its approval. Eligibility, blood-pressure considerations, and other risks need a clinician’s review.

THE DETAILS MATTER

Good questions. Clear answers.

Is compounded PT-141 the same as an approved medication?

An FDA-approved bremelanotide product has a specific indication and dosing presentation. A compounded PT-141 formulation is not that approved product and does not inherit its approval. Eligibility, blood-pressure considerations, and other risks need a clinician’s review.

What is included in the listed price?

Every listed price is for one specified vial and includes the asynchronous consultation, supplies, and two-day shipping. It is not a monthly subscription price. Shipping transit begins after dispensing; clinician review and pharmacy preparation take additional time.

What does clinician-supervised mean?

A licensed clinician reviews your health history, current medications, and the reason you are seeking care. They decide whether treatment is appropriate. A catalog listing or completed consultation does not guarantee a prescription. Pharmacy and state requirements also apply.

Are these formulations FDA-approved?

The compounded formulations in this catalog are not FDA-approved. FDA does not review compounded drugs for safety, effectiveness, or quality before marketing. Several listed peptides have limited human safety data and specific FDA-identified safety concerns; see each treatment page and our clinical information page.

YOUR NEXT STEP

Less guesswork.
More guidance.

Start with a conversation about what makes sense for you.

Explore your next step

A clinician decides.
You stay informed.

Clear formulations. Transparent pricing.
No promises your health should have to rely on.